New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma.
- Resource Type
- Article
- Authors
- Aggen, David H; Garcia, Alejandro; Saro Suarez, Jose M; Sauer, Amy; Cristiani, Sebastiano; Brophy, Francine Elizabeth; Streets, Sharon; Norry, Elliot; Nelson, Ariel Ann; Kilari, Deepak; Garmezy, Benjamin; Charlson, John A.; Zugazagoitia, Jon; Calvo, Emiliano; Moreno, Irene; Moreno, Victor; Hoimes, Christopher J.; Hong, David S.; Cervantes, Andres
- Source
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS708-TPS708, 193p
- Subject
- Language
- ISSN
- 0732183X